This year we are celebrating 25 years of smarter studies, global impact, and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements.
Latest News
'25 at 25': Improving prostate cancer diagnosis
As part of our ‘25 at 25’ series, we look at how the PROMIS study has improved how prostate cancer is diagnosed, sparing thousands of men unnecessary biopsies.
13 Nov
Our TB research at The Union World Conference on Lung Health 2024
Our TB research at The Union World Conference on Lung Health 2024
11 Nov
New podcast roundup of early career researchers at ICTMC 2024
This latest episode of the Trial Talk podcast features four of the Unit’s early career researchers, each discussing the work they presented at ICTMC 2024.
30 Oct
'25 at 25': Framework for Adaptive Meta-analysis (FAME) for timely, reliable and thorough results
In the latest in our ‘25 at 25’ series, we explore FAME – a collaborative approach to prospective meta-analysis of aggregate data, which speeds up the delivery of reliable and thorough results.
29 Oct
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes